The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Open accessPublished version of a preprint
Abstract
We previously piloted the concept of a Connectivity Map (CMap), whereby genes, drugs, and disease states are connected by virtue of common gene-expression signatures. Here, we report more than a 1,000-fold scale-up of the CMap as part of the NIH LINCS Consortium, made possible by a new, low-cost, high-throughput reduced representation expression profiling method that we term L1000. We show that L1000 is highly reproducible, comparable to RNA sequencing, and suitable for computational inference of the expression levels of 81% of non-measured transcripts. We further show that the expanded CMap can be used to discover mechanism of action of small molecules, functionally annotate genetic variants of disease genes, and inform clinical trials. The 1.3 million L1000 profiles described here, as well as tools for their analysis, are available at https://clue.io.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of gene expression changes has been reported to correlate with functional impact (Wawer et al. 2014; Subramanian et al. 2017)”
From Murine single-cell RNA-seq reveals cell-identity- and tissue-specific trajectories of aging (2019) · cites this paper as Subramanian et al. 2017
Experimental — accuracy not yet measuredIn the citing paper
“many transcriptional states could be faithfully inferred from a subset of gene expression measurements32,33”
From Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing (2020) · cites this paper as [33]
In the citing paper
“Alternatively, gene panels such as the L1000 panel34 could be used (Extended Data Figure 3), which has been shown to capture the majority of information contained in the full transcriptome across a wide range of perturbations34.”
From Targeted Perturb-seq enables genome-scale genetic screens in single cells (2020) · cites this paper as [34]
In the citing paper
“Perturbation modelling is underpinned by systematic databases of biological response to treatment (e.g. Connectivity Map [2], L1000, DRUG-seq [3]) and leverages the significant potential of machine learning (ML) to make predictive models, e.g., molecular targets or IC50 values.”
From A mini-review on perturbation modelling across single-cell omic modalities (2024) · cites this paper as [2]
In the citing paper
“Of note, the LINCS consortium, and in particular the L1000 Connectivity Map resource, provides a catalog of postperturbation transcriptomics profiles for thousands of compounds, offering a global map of the phenotypic response landscape of the medicinal chemistry space.205”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [205]
In the citing paper
“Another caveat of our approach is the likely existence of null signatures corresponding to innocuous molecules with no actual bioactivity in a given CC data type38.”
From Bioactivity descriptors for uncharacterized chemical compounds (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citation(2008) · Journal of Machine Learning Research · Cited by 33,051
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Open Babel: An open chemical toolbox
O'Boyle, N. M., Banck, M. S., James, C. A. J., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011) · Journal of Cheminformatics · doi:10.1186/1758-2946-3-33 · Cited by 10,745
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Self-citationThe Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Self-citationDefining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Illumina Inc. (2007). BeadStudio Normalization Algorithms for Gene Expression Data (Illumina Technical Bulletin Pub. No.470-2007-005).
Cited by
Sorted by citations
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., Kamińska, B., Huelsken, J., Omberg, L., Gevaert, O., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.034 · Cited by 2,180
Self-citationA Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Jerby-Arnon, L., Shah, P., Cuoco, M. S., Rodman, C., Su, M.-J., Melms, J. C., Leeson, R., Kanodia, A., Mei, S., Lin, J.-R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.006 · Cited by 1,429
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X. Y., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,071
Genetic and transcriptional evolution alters cancer cell line drug response
Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., Strathdee, C. A., Dempster, J., Lyons, N. J., Burns, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0409-3 · Cited by 931
Self-citationDiscovering the anticancer potential of non-oncology drugs by systematic viability profiling
Corsello, S. M., Nagari, R. T., Spangler, R. D., Rossen, J., Kocak, M., Bryan, J. G., Humeidi, R., Peck, D., Wu, X., Tang, A. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-019-0018-6 · Cited by 878
Self-citationSynergy and antagonism in natural product extracts: when 1 + 1 does not equal 2
Caesar, L. K., & Cech, N. B. (2019) · Natural Product Reports · doi:10.1039/c9np00011a · Cited by 979
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Gillette, M. A., Satpathy, S., Cao, S., Dhanasekaran, S. M., Vasaikar, S. V., Krug, K., Petralia, F., Li, Y., Liang, W.-W., Reva, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.013 · Cited by 820
Self-citationArtificial Intelligence in Cancer Research and Precision Medicine
Bhinder, B., Gilvary, C., Madhukar, N. S., & Elemento, O. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0090 · Cited by 781
MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices
McGinnis, C. S., Patterson, D. M., Winkler, J., Conrad, D. N., Hein, M. Y., Srivastava, V., Hu, J. L., Murrow, L. M., Weissman, J. S., Werb, Z., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0433-8 · Cited by 643
HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine
Fang, S., Dong, L., Liu, L., Guo, J., Zhao, L., Zhang, J.-Y., Bu, D., Liu, X., Huo, P., Cao, W., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1063 · Cited by 710
Proteogenomic and metabolomic characterization of human glioblastoma
Wang, L.-B., Karpova, A., Gritsenko, M. A., Kyle, J. E., Cao, S., Li, Y., Rykunov, D., Colaprico, A., Rothstein, J. H., Hong, R., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.006 · Cited by 661
Deep learning improves prediction of drug–drug and drug–food interactions
Ryu, J. Y., Kim, H. U., & Lee, S. Y. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803294115 · Cited by 676
TTD: Therapeutic Target Database describing target druggability information
Zhou, Y., Zhang, Y., Zhao, D., Yu, X., Shen, X., Zhou, Y., Wang, S., Qiu, Y., Chen, Y., & Zhu, F. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad751 · Cited by 683
Bressan, D., Battistoni, G., & Hannon, G. J. (2023) · Science · doi:10.1126/science.abq4964 · Cited by 622
Stroke genetics informs drug discovery and risk prediction across ancestries
Mishra, A., Malik, R., Hachiya, T., Jürgenson, T., Namba, S., Posner, D. C., Kamanu, F., Koido, M., Grand, Q. L., Shi, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05165-3 · Cited by 609
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Krug, K., Jaehnig, E. J., Satpathy, S., Blumenberg, L. M., Karpova, A. Y., Anurag, M., Miles, G., Mertins, P., Geffen, Y., Tang, L. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.036 · Cited by 543
Trans effects on gene expression can drive omnigenic inheritance
Liu, X., Li, Y. I., & Pritchard, J. K. (2019) · Cell · doi:10.1016/j.cell.2019.04.014 · Cited by 523
The International League Against Epilepsy Consortium on Complex Epilepsies, Abou-Khalil, B., Auce, P., Avbersek, A., Bahlo, M., Balding, D. J., Bast, T., Baum, L., Becker, A. J., Becker, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07524-z · Cited by 482
Targeting metabolic dysregulation for fibrosis therapy
Zhao, X. L., Kwan, J. Y. Y., Yip, K. W., Liu, P. P., & Liu, F. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0040-5 · Cited by 531
The quest to slow ageing through drug discovery
Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0067-7 · Cited by 468
Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing
Replogle, J. M., Norman, T. M., Xu, A., Hussmann, J. A., Chen, J., Cogan, J. Z., Meer, E. J., Terry, J. M., Riordan, D. P., Srinivas, N., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0470-y · Cited by 465
Massively multiplex chemical transcriptomics at single-cell resolution
Srivatsan, S. R., McFaline-Figueroa, J. L., Ramani, V., Saunders, L., Cao, J., Packer, J., Pliner, H. A., Jackson, D. L., Daza, R. M., Christiansen, L., et al. (2020) · Science · doi:10.1126/science.aax6234 · Cited by 401
Artificial intelligence in cancer target identification and drug discovery
You, Y., Lai, X., Pan, Y. F., Zheng, H., Vera, J., Liu, S., Deng, S., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00994-0 · Cited by 487
Keenan, A. B., Jenkins, S. L., Jagodnik, K. M., Koplev, S., He, E., Torre, D., Wang, Z., Dohlman, A. B., Silverstein, M. C., Lachmann, A., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2017.11.001 · Cited by 423
Self-citationMéndez‐Lucio, O., Baillif, B., Clevert, D.-A., Rouquié, D., & Wichard, J. (2020) · Nature Communications · doi:10.1038/s41467-019-13807-w · Cited by 436
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 446
Self-citationWhy Hypothesis Testers Should Spend Less Time Testing Hypotheses
Scheel, A. M., Tiokhin, L., Isager, P. M., & Lakens, D. (2021) · Perspectives on Psychological Science · doi:10.1177/1745691620966795 · Cited by 382
Image-based profiling for drug discovery: due for a machine-learning upgrade?
Chandrasekaran, S. N., Ceulemans, H., Boyd, J. D., & Carpenter, A. E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00117-w · Cited by 407
Deep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Ella, H. A., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2022) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 423
A proteogenomic portrait of lung squamous cell carcinoma
Satpathy, S., Krug, K., Beltran, P. M. J., Savage, S. R., Petralia, F., Kumar‐Sinha, C., Dou, Y., Reva, B. A., Kane, M. H., Avanessian, S. C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.016 · Cited by 384
Sakornsakolpat, P., Prokopenko, D., Lamontagne, M., Reeve, N. F., Guyatt, A. L., Jackson, V. E., Shrine, N. R. G., Qiao, D., Bartz, T. M., Kim, D. K., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0342-2 · Cited by 377
Dictionary of immune responses to cytokines at single-cell resolution
Cui, A., Huang, T., Li, S., Ma, A., Pérez, J. L., Sander, C., Keskin, D. B., Wu, C. J., Fraenkel, E., & Hacohen, N. (2023) · Nature · doi:10.1038/s41586-023-06816-9 · Cited by 371
Phenotypic drug discovery: recent successes, lessons learned and new directions
Vincent, F., Nueda, A., Lee, J. L. C., Schenone, M., Prunotto, M., & Mercola, M. A. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00472-w · Cited by 388
Wei, L., Lee, D., Law, C.-T., Zhang, M. S., Shen, J., Chin, D. W.-C., Zhang, A., Tsang, F. H.-C., Wong, C. L.-S., Ng, I. O.-L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12606-7 · Cited by 428
Jarada, T. N., Rokne, J. G., & Alhajj, R. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00450-7 · Cited by 384
Independent Drug Action in Combination Therapy: Implications for Precision Oncology
Plana, D., Palmer, A. C., & Sorger, P. K. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0212 · Cited by 336
Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
Petralia, F., Tignor, N., Reva, B., Koptyra, M., Chowdhury, S., Rykunov, D., Krek, A., Ma, W., Zhu, Y., Ji, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.044 · Cited by 317
Empowering biomedical discovery with AI agents
Gao, S., Fang, A., Huang, Y., Giunchiglia, V., Noori, A., Schwarz, J. R., Ektefaie, Y., Kondic, J., & Zitnik, M. (2024) · Cell · doi:10.1016/j.cell.2024.09.022 · Cited by 315
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Enache, O. M., Rendo, V., Abdusamad, M., Lam, D., Davison, D., Pal, S., Currimjee, N., Hess, J., Pantel, S., Nag, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0623-4 · Cited by 285
Self-citationMolecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Montal, R., Sia, D., Montironi, C., Leow, W. Q., Esteban-Fabró, R., Pinyol, R., Torres‐Martín, M., Bassaganyas, L., Moeini, A., Peix, J., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.008 · Cited by 309
Ge, Y., Tian, T., Huang, S., Wan, F., Li, J., Li, S., Wang, X., Yang, H., Hong, L., Wu, N., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00568-6 · Cited by 300
Assessment of network module identification across complex diseases
Choobdar, S., Ahsen, M. E., Crawford, J., Tomasoni, M., Fang, T., Lamparter, D., Lin, J., Hescott, B. J., Hu, X., Mercer, J., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0509-5 · Cited by 300
Self-citationAneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition
Cohen‐Sharir, Y., McFarland, J. M., Abdusamad, M., Marquis, C., Bernhard, S. V., Kazachkova, M., Tang, H., Ippolito, M. R., Laue, K., Zerbib, J., et al. (2021) · Nature · doi:10.1038/s41586-020-03114-6 · Cited by 283
Self-citationTranscription factors: Bridge between cell signaling and gene regulation
Weidemüller, P., Kholmatov, M. M., Petsalaki, E., & Zaugg, J. B. (2021) · PROTEOMICS · doi:10.1002/pmic.202000034 · Cited by 295
Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
(DeCOI), G. C.-1. O. I., Aschenbrenner, A. C., Mouktaroudi, M., Krämer, B., Oestreich, M., Antonakos, N., Nuesch-Germano, M., Gkizeli, K., Bonaguro, L., Reusch, N., et al. (2021) · Genome Medicine · doi:10.1186/s13073-020-00823-5 · Cited by 255
Advancing the use of genome-wide association studies for drug repurposing
Reay, W. R., & Cairns, M. J. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00387-z · Cited by 284
A new era in functional genomics screens
Przybyla, L., & Gilbert, L. A. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00409-w · Cited by 281
Machine and deep learning approaches for cancer drug repurposing
Issa, N. T., Stathias, V., Schürer, S. C., & Dakshanamurthy, S. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.12.011 · Cited by 288
The evolving role of investigative toxicology in the pharmaceutical industry
Pognan, F., Beilmann, M., Boonen, H. C. M., Czich, A., Dear, G. J., Hewitt, P. G., Mow, T. J., Oinonen, T., Roth, A. B., Steger‐Hartmann, T., et al. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00633-x · Cited by 280
The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1
Cheff, D. M., Huang, C., Scholzen, K., Gencheva, R., Ronzetti, M. H., Cheng, Q., Hall, M. D., & Arnér, E. S. J. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102703 · Cited by 266
Big data in basic and translational cancer research
Jiang, P., Sinha, S., Aldape, K., Hannenhalli, S., Sahinalp, C., & Ruppin, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00502-0 · Cited by 254
Targeted Perturb-seq enables genome-scale genetic screens in single cells
Schraivogel, D., Gschwind, A. R., Milbank, J. H., Leonce, D. R., Jakob, P., Mathur, L., Korbel, J. O., Merten, C. A., Velten, L., & Steinmetz, L. M. (2020) · Nature Methods · doi:10.1038/s41592-020-0837-5 · Cited by 245
Genome-wide association study of medication-use and associated disease in the UK Biobank
Wu, Y., Byrne, E. M., Zheng, Z., Kemper, K. E., Yengo, L., Mallett, A. J., Yang, J., Visscher, P. M., & Wray, N. R. (2019) · Nature Communications · doi:10.1038/s41467-019-09572-5 · Cited by 243
GSEA-InContext: identifying novel and common patterns in expression experiments
Powers, R. K., Goodspeed, A., Pielke-Lombardo, H., Tan, A. C., & Costello, J. C. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty271 · Cited by 241
Hatoum, A. S., Colbert, S. M. C., Johnson, E. C., Huggett, S. B., Deak, J. D., Pathak, G. A., Jennings, M. V., Paul, S. E., Karcher, N. R., Hansen, I., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00034-y · Cited by 241
Deep learning for drug response prediction in cancer
Baptista, D., Ferreira, P. G., & Rocha, M. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz171 · Cited by 243
Network-Based Methods for Prediction of Drug-Target Interactions
Wu, Z., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01134 · Cited by 246
Stein, M. B., Levey, D. F., Cheng, Z., Wendt, F. R., Harrington, K. M., Pathak, G. A., Cho, K., Quaden, R. M., Radhakrishnan, K., Girgenti, M. J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00767-x · Cited by 235
Diverse compounds from pleuromutilin lead to a thioredoxin inhibitor and inducer of ferroptosis
Llabani, E., Hicklin, R. W., Lee, H. Y., Motika, S. E., Crawford, L. A., Weerapana, E., & Hergenrother, P. J. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0261-6 · Cited by 234
Chemical probes and drug leads from advances in synthetic planning and methodology
Gerry, C. J., & Schreiber, S. L. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.53 · Cited by 232
Self-citationMachine learning applications in drug development
Réda, C., Kaufmann, E., & Delahaye‐Duriez, A. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.006 · Cited by 235
Ciallella, H. L., & Zhu, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00393 · Cited by 227
Artificial intelligence, machine learning, and drug repurposing in cancer
Tanoli, Z., Vähä-Koskela, M. J. V., & Aittokallio, T. A. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1883585 · Cited by 224
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
Ye, C., Ho, D. J., Neri, M., Yang, C., Kulkarni, T., Randhawa, R., Henault, M., Mostacci, N., Farmer, P., Renner, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06500-x · Cited by 222
Pham, T.-H., Qiu, Y., Zeng, J., Xie, L., & Zhang, P. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-020-00285-9 · Cited by 225
Genetics of Atrial Fibrillation in 2020
Roselli, C., Rienstra, M., & Ellinor, P. T. (2020) · Circulation Research · doi:10.1161/circresaha.120.316575 · Cited by 218
Luna, A., Elloumi, F., Varma, S., Wang, Y., Rajapakse, V. N., Aladjem, M. I., Robert, J., Sander, C., Pommier, Y. G., & Reinhold, W. C. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa968 · Cited by 212
Murine single-cell RNA-seq reveals cell-identity- and tissue-specific trajectories of aging
Kimmel, J. C., Penland, L., Rubinstein, N. D., Hendrickson, D. G., Kelley, D. R., & Rosenthal, A. Z. (2019) · Genome Research · doi:10.1101/gr.253880.119 · Cited by 184
An omics perspective on drug target discovery platforms
Paananen, J., & Fortino, V. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz122 · Cited by 216
Drug repositioning and repurposing for Alzheimer disease
Ballard, C., Aarsland, D., Cummings, J., O’Brien, J., Mills, R., Molinuevo, J. L., Fladby, T., Williams, G., Doherty, P., Corbett, A., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0397-4 · Cited by 201
Omics Advances in Ecotoxicology
Zhang, X., Xia, P., Wang, P., Yang, J., & Baird, D. J. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.7b06494 · Cited by 214
GREIN: An Interactive Web Platform for Re-analyzing GEO RNA-seq Data
Mahi, N. A., Najafabadi, M. F., Pilarczyk, M., Kouril, M., & Medvedovic, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-43935-8 · Cited by 209
Quantifying drug combination synergy along potency and efficacy axes
Meyer, C. T., Wooten, D. J., Paudel, B. B., Bauer, J., Hardeman, K. N., Westover, D., Lovly, C. M., Harris, L. A., Tyson, D. R., & Quaranta, V. (2019) · Cell Systems · doi:10.1016/j.cels.2019.01.003 · Cited by 202
Integrated multi-omics approaches to improve classification of chronic kidney disease
Eddy, S. F., Mariani, L. H., & Kretzler, M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0286-5 · Cited by 204
Noncanonical open reading frames encode functional proteins essential for cancer cell survival
Prensner, J. R., Enache, O. M., Luria, V., Krug, K., Clauser, K. R., Dempster, J. M., Karger, A., Wang, L., Stumbraite, K., Wang, V. M., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00806-2 · Cited by 201
Self-citationMcFarland, J. M., Paolella, B. R., Warren, A., Geiger-Schuller, K., Shibue, T., Rothberg, M., Kuksenko, O., Colgan, W. N., Jones, A., Chambers, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17440-w · Cited by 173
Self-citationL1000FWD: fireworks visualization of drug-induced transcriptomic signatures
Wang, Z., Lachmann, A., Keenan, A. B., & Ma’ayan, A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty060 · Cited by 195
Machine Learning and Artificial Intelligence in Toxicological Sciences
Lin, Z., & Chou, W. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac075 · Cited by 204
Smith, I. C. P., Greenside, P., Natoli, T. E., Lahr, D. L., Wadden, D., Tirosh, I., Narayan, R., Root, D. E., Golub, T. R., Subramanian, A., et al. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2003213 · Cited by 197
Self-citationPrediction of drug efficacy from transcriptional profiles with deep learning
Zhu, J., Wang, J., Wang, X., Gao, M., Guo, B., Gao, M., Liu, J., Yu, Y., Wang, L., Kong, W., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00946-z · Cited by 193
Self-citationTumour evolution and microenvironment interactions in 2D and 3D space
Mo, C.-K., Liu, J., Chen, S., Storrs, E. P., da Costa, A. L. N. T., Houston, A., Wendl, M. C., Jayasinghe, R. G., Iglesia, M. D., Ma, C., et al. (2024) · Nature · doi:10.1038/s41586-024-08087-4 · Cited by 198
An Overview of Machine Learning and Big Data for Drug Toxicity Evaluation
Vo, A. H., Vleet, T. R. V., Gupta, R. R., Liguori, M. J., & Rao, M. S. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00227 · Cited by 196
MatchMaker: A Deep Learning Framework for Drug Synergy Prediction
Kuru, H. İ., Taştan, Ö., & Çiçek, A. E. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3086702 · Cited by 192
Deep learning for drug repurposing: Methods, databases, and applications
Pan, X., Lin, X., Cao, D., Zeng, X., Yu, P. S., He, L., Nussinov, R., & Cheng, F. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1597 · Cited by 200
Advancing Computational Toxicology by Interpretable Machine Learning
Jia, X., Wang, T., & Zhu, H. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c00653 · Cited by 197
High-Throughput Transcriptomics Platform for Screening Environmental Chemicals
Harrill, J., Everett, L. J., Haggard, D. E., Sheffield, T. Y., Bundy, J. L., Willis, C. M., Thomas, R. S., Shah, I., & Judson, R. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab009 · Cited by 195
Wang, M., Li, A., Sekiya, M., Beckmann, N. D., Quan, X., Schrode, N., Fernando, M. B., Yu, A., Zhu, L., Cao, J., et al. (2021) · Neuron · doi:10.1016/j.neuron.2020.11.002 · Cited by 185
High-Throughput Methods in the Discovery and Study of Biomaterials and Materiobiology
Yang, L., Pijuan‐Galito, S., Rho, H. S., Vasilevich, A. S., Eren, A. D., Ge, L., Habibović, P., Alexander, M. R., de Boer, J., Carlier, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00752 · Cited by 189
Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals
Zhou, H., Kember, R. L., Deak, J. D., Xu, H., Toikumo, S., Yuan, K., Lind, P. A., Farajzadeh, L., Wang, L., Hatoum, A. S., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02653-5 · Cited by 179
Dr.VAE: improving drug response prediction via modeling of drug perturbation effects
Rampášek, L., Hidru, D., Smirnov, P., Haibe‐Kains, B., & Goldenberg, A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz158 · Cited by 174
Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives
Romano, J. D., & Tatonetti, N. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00368 · Cited by 183
Jin, H., Zhang, C., Zwahlen, M., von Feilitzen, K., Karlsson, M., Shi, M., Yuan, M., Song, X., Li, X., Yang, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41132-w · Cited by 188
Mandula, J. K., Chang, S., Mohamed, E. T., Jimenez, R., Sierra-Mondragon, R. A., Chang, D., Obermayer, A., Segura, C. M., Das, S., Vázquez-Martínez, J. A., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.016 · Cited by 177
Distinct longevity mechanisms across and within species and their association with aging
Tyshkovskiy, A., Ma, S., Shindyapina, A. V., Tikhonov, S., Lee, S.-G., Bozaykut, P., Castro, J. P., Seluanov, A., Schork, N. J., Gorbunova, V., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.002 · Cited by 162
Molecular design in drug discovery: a comprehensive review of deep generative models
Cheng, Y., Gong, Y., Liu, Y., Song, B., & Zou, Q. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab344 · Cited by 178
Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models
Zhang, T., Zhang, L., Payne, P., & Li, F. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0849-4_12 · Cited by 175
Mouse models of colorectal cancer: Past, present and future perspectives
Bürtin, F., Mullins, C. S., & Linnebacher, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i13.1394 · Cited by 180
Identification and Application of Gene Expression Signatures Associated with Lifespan Extension
Tyshkovskiy, A., Bozaykut, P., Borodinova, A. A., Gerashchenko, M. V., Ables, G. P., Garratt, M., Khaitovich, P., Clish, C. B., Miller, R. A., & Gladyshev, V. N. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.018 · Cited by 167
Single-cell genomics and regulatory networks for 388 human brains
Emani, P. S., Liu, J. J., Clarke, D., Jensen, M., Warrell, J., Gupta, C., Meng, R., Lee, C.-Y., Xu, S., Dursun, C., et al. (2024) · Science · doi:10.1126/science.adi5199 · Cited by 171
Identification of disease treatment mechanisms through the multiscale interactome
Ruiz, C., Zitnik, M., & Leskovec, J. (2021) · Nature Communications · doi:10.1038/s41467-021-21770-8 · Cited by 172
Metadata
- Authors
- Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., Lahr, D. L., Hirschman, J. E., Liu, Z., Donahue, M., Julian, B., Khan, M., Wadden, D., Smith, I. C., Lam, D., Liberzon, A., Toder, C., Bagul, M., Orzechowski, M., Enache, O. M., Piccioni, F., Johnson, S. A., Lyons, N. J., Berger, A. H., Shamji, A. F., Brooks, A. N., Vrcic, A., Flynn, C., Rosains, J., Takeda, D. Y., Hu, R., Davison, D., Lamb, J., Ardlie, K., Hogstrom, L., Greenside, P., Gray, N. S., Clemons, P. A., Silver, S., Wu, X., Zhao, W.-N., Read-Button, W., Wu, X., Haggarty, S. J., Ronco, L. V., Boehm, J. S., Schreiber, S. L., Doench, J. G., Bittker, J. A., Root, D. E., Wong, B., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Golub, Todd R.
- ORCID
- Subramanian, Aravind
- Corsello, Steven M.
- Gould, Joshua
- Tubelli, Andrew A.
- Lahr, David L.
- Hirschman, Jodi E.
- Liu, Zihan
- Khan, Mariya
- Smith, Ian C.
- Orzechowski, Marek
- Enache, Oana M.
- Piccioni, Federica
- Johnson, Sarah A.
- Berger, Alice H.
- Brooks, Angela N.
- Vrcic, Anita
- Takeda, David Y.
- Ardlie, Kristin
- Gray, Nathanael S.
- Clemons, Paul A.
- Silver, Serena
- Wu, Xiaoyun
- Zhao, Wen-Ning
- Haggarty, Stephen J.
- Ronco, Lucienne V.
- Boehm, Jesse S.
- Schreiber, Stuart L.
- Doench, John G.
- Bittker, Joshua A.
- Root, David E.
- Golub, Todd R.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 171
- Issue
- 6
- Pages
- 1437-1452.e17
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5990023
- OpenAlex
- W2612467560
- Cited by
- 3,515
- References
- 73
- Citations by year
- 2026: 436 · 2025: 479 · 2024: 493 · 2023: 458 · 2022: 507 · 2021: 421 · 2020: 320 · 2019: 261 · 2018: 122 · 2017: 12
- FWCI
- 80.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (U54HG006093, U54HL127366, U01HG008699, CA009172, TR001100)
- Conquer Cancer Foundation of ASCO Young
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- Connectivity Map, L1000, gene expression signatures, functional annotation of genetic variants, reproducibility, clinical trial design
- MeSH terms
- Pharmaceutical Preparations, Humans, Neoplasms, Organ Specificity, Sequence Analysis, RNA, Drug Resistance, Neoplasm, Gene Expression Profiling, Cell Line, Tumor, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
